Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.

Ritter, J., Creutzig, U., & Schellong, G. (1990). Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83. Haematology and Blood Transfusion, 33, 185–192. https://doi.org/10.1007/978-3-642-74643-7_35